Oncologic Imaging in the Era of Molecular Medicine

Oncologic Imaging in the Era of Molecular Medicine

Wednesday, Dec. 1, 8:30 AM - 10:00 AM

The session is focusing on advances in oncologic imaging including the value of PET/CT in staging, early treatment response and prognosis and sharing clinical data about the development of novel PET tracers. Other topics include MRI techniques for assessing therapeutic response and imaging of apoptosis.

The speakers are:
  • Juri G. Gelovani, MD, PhD, chair, department of experimental diagnostic imaging, MD Anderson Cancer Center in Houston;
  • Anwar R. Padhani, MD, radiology, Mount Vernon Hospital in London; and
  • Francis G. Blankenberg, MD, associate professor of radiology, Lucile Packard Children’s Hospital in Stanford, Calif.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.